Feasibility and preliminary efficacy of R-CHOP-14 in patients with diffuse large B-Cell lymphoma (DLBCL).

被引:0
|
作者
Halaas, JL [1 ]
Moskowitz, CH [1 ]
Noy, A [1 ]
Portlock, C [1 ]
Horwitz, S [1 ]
Straus, D [1 ]
O'Connor, O [1 ]
Yahalom, J [1 ]
Zelenetz, AD [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6584
引用
收藏
页码:578S / 578S
页数:1
相关论文
共 50 条
  • [21] Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma
    Bozzoli, Valentina
    Tisi, Maria C.
    Maiolo, Elena
    Alma, Eleonora
    Bellesi, Silvia
    D'Alo', Francesco
    Voso, Maria T.
    Leone, Giuseppe
    Hohaus, Stefan
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (06) : 787 - 794
  • [22] Diffuse large B-cell lymphoma: R-CHOP forever?
    Jedrzejczak, Wieslaw W.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (10): : 713 - 714
  • [23] Comparison between R-mini-CHOP and R-Bendamustine in diffuse large B-cell lymphoma (DLBCL) of elderly and comorbid patients
    Hammersen, F. J.
    Ruethrich, M. M.
    Kleber, M.
    Wedding, U.
    Sommer, M.
    Mueller, D.
    Schlattmann, P.
    Hochhaus, A.
    La Rosee, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 143 - 144
  • [24] Outcomes of Patients with Transformed Diffuse Large B-Cell Lymphoma (DLBCL)
    Nakashima, J.
    Cruz-Chamarro, R.
    Laborde, J.
    Kim, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E479 - E479
  • [25] Phase II trial of split-dose R-CHOP for older patients with diffuse large B-cell lymphoma (DLBCL)
    Shah, Nirav Niranjan
    Szabo, Aniko
    Rajguru, Saurabh
    Devata, Sumana
    Howard, Mitch
    Pereira, Deepa
    Endres, Mariah
    Longo, Walter L.
    Hamadani, Mehdi
    Fenske, Timothy S.
    Fletcher, Christopher David
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Has R-CHOP Really Been Replaced as Initial Therapy of Diffuse Large B-cell Lymphoma (DLBCL)?
    Friedberg, Jonathan W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S89 - S90
  • [27] R-CHOP compared with CHOP in patients with diffuse large B-cell lymphoma (DLCL): Russian experience
    Poddubnaya, I.
    Osmanov, E.
    Babicheva, L.
    Tumyan, G.
    Sorokin, E.
    Stefanov, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma
    Carol S. Portlock
    Current Oncology Reports, 2003, 5 (5) : 357 - 357
  • [29] Dose dense R-CHOP-14 may be superior to conventional R-CHOP-21 with comparable toxicities in Asian patients with high risk Diffuse Large B Cell Lymphoma
    Tai, W.
    Tan, I. B.
    Tan, M. Y.
    Ngeow, Y. Y.
    Koo, Y. X.
    Tao, M.
    Quek, R.
    Lim, S. T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 563 - 563
  • [30] Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma
    Camus, Vincent
    Tilly, Herve
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (12) : 1047 - 1055